Current Vaccine Developments:

Updated COVID-19 vaccines for 2024-2025 target the KP.2 variant, addressing recent changes in circulating strains. These vaccines focus on preventing severe illness, hospitalizations, and death rather than blocking infections entirely.

Vaccination remains recommended for everyone, with a focus on older adults and those with underlying health conditions. Vaccines are also shown to reduce the risk of long COVID symptoms​